Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients
暂无分享,去创建一个
Jeroen J. Bax | S. Hoeks | E. Boersma | D. Poldermans | O. Schouten | W. Flu | D. Goei | T. Winkel | M. Dunkelgrun
[1] Fred S Apple,et al. Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.
[2] S. Chae,et al. Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[3] J. Dernellis,et al. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients , 2006, Heart.
[4] Jeroen J. Bax,et al. Baseline plasma N-terminal pro-B-type natriuretic peptide is associated with the extent of stress-induced myocardial ischemia during dobutamine stress echocardiography. , 2006, Coronary artery disease.
[5] A. Kastrati,et al. Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Patients With Chronic Stable Angina , 2005, Circulation.
[6] H. Yeh,et al. Preoperative plasma N‐terminal pro‐brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non‐cardiac surgery , 2005, The British journal of surgery.
[7] P. Houillier,et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. , 2005, Journal of the American Society of Nephrology : JASN.
[8] L. Køber,et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.
[9] R. Schnabel,et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. , 2005, European heart journal.
[10] F. Triposkiadis,et al. Routine measurement of radioisotope left ventricular ejection fraction prior to vascular surgery: is it worthwhile? , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[11] O. Wagner,et al. Joint Effects of C-Reactive Protein and Glycated Hemoglobin in Predicting Future Cardiovascular Events of Patients With Advanced Atherosclerosis , 2003, Circulation.
[12] R. Califf,et al. N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy , 2003, Circulation.
[13] Mark B Pepys,et al. C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.
[14] C. Visser,et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? , 1999, Circulation.
[15] E. Antman,et al. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy , 1998 .
[16] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[17] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[18] H. Itoh,et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. , 1995, Circulation.
[19] K. Nakao,et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.
[20] K. Kugiyama,et al. Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.
[21] D. Mangano. Perioperative cardiac morbidity , 1990, Anesthesiology.
[22] Jeroen J. Bax,et al. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. , 2008, The American journal of cardiology.
[23] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[24] J. Mair,et al. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. , 2001, Clinical laboratory.
[25] E. Antman,et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. , 1998, Journal of the American College of Cardiology.
[26] C. Frampton,et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. , 1993, The Journal of clinical endocrinology and metabolism.